CareTrust REIT, Inc. (NASDAQ:CTRE) Expected to Announce Quarterly Sales of $44.70 Million

Thursday, April 8, 2021 | MarketBeat

Equities research analysts predict that CareTrust REIT, Inc. (NASDAQ:CTRE) will announce sales of $44.70 million for the current fiscal quarter, Zacks Investment Research reports. Four analysts have provided estimates for CareTrust REIT's earnings. The lowest sales estimate is $43.74 million and the highest is $45.50 million. CareTrust REIT posted sales of $44.34 million during the same quarter last year, which suggests a positive year-over-year growth rate of 0.8%. The company is scheduled to report its next quarterly earnings report on Thursday, May 6th.

On average, analysts expect that CareTrust REIT will report full-year sales of $180.60 million for the current fiscal year, with estimates ranging from $175.10 million to $186.10 million. For the next financial year, analysts forecast that the business will post sales of $187.25 million, with estimates ranging from $178.24 million to $203.40 million. Zacks' sales calculations are a mean average based on a survey of analysts that that provide coverage for CareTrust REIT.

CareTrust REIT (NASDAQ:CTRE) last announced its quarterly earnings data on Tuesday, February 9th. The real estate investment trust reported $0.22 earnings per share for the quarter, missing the Thomson Reuters' consensus estimate of $0.36 by ($0.14). CareTrust REIT had a net margin of 45.10% and a return on equity of 8.74%.

Several research analysts have recently weighed in on the stock. BMO Capital Markets upgraded shares of CareTrust REIT from a "market perform" rating to an "outperform" rating and boosted their price objective for the stock from $25.00 to $26.00 in a research note on Thursday, January 7th. Zacks Investment Research upgraded CareTrust REIT from a "sell" rating to a "hold" rating in a research note on Thursday, March 4th. KeyCorp raised CareTrust REIT from a "sector weight" rating to an "overweight" rating and set a $24.00 price target for the company in a report on Monday, December 14th. Raymond James reissued a "buy" rating and issued a $25.00 price objective on shares of CareTrust REIT in a research report on Friday, March 5th. Finally, Barclays upped their price target on shares of CareTrust REIT from $21.00 to $25.00 and gave the company an "overweight" rating in a research note on Tuesday, January 19th. Two investment analysts have rated the stock with a hold rating and eight have issued a buy rating to the company. The stock presently has an average rating of "Buy" and an average target price of $23.11.

NASDAQ CTRE opened at $24.22 on Thursday. CareTrust REIT has a 12 month low of $14.87 and a 12 month high of $24.89. The company has a current ratio of 1.16, a quick ratio of 1.16 and a debt-to-equity ratio of 0.54. The stock has a 50 day moving average of $23.25 and a 200-day moving average of $21.20. The company has a market cap of $2.33 billion, a PE ratio of 28.49 and a beta of 1.11.

The firm also recently declared a quarterly dividend, which will be paid on Thursday, April 15th. Stockholders of record on Wednesday, March 31st will be given a $0.265 dividend. This represents a $1.06 dividend on an annualized basis and a dividend yield of 4.38%. This is an increase from CareTrust REIT's previous quarterly dividend of $0.25. The ex-dividend date is Tuesday, March 30th. CareTrust REIT's payout ratio is presently 77.94%.

Several hedge funds have recently modified their holdings of CTRE. First Trust Advisors LP raised its holdings in CareTrust REIT by 37.7% in the 1st quarter. First Trust Advisors LP now owns 171,743 shares of the real estate investment trust's stock valued at $4,029,000 after acquiring an additional 47,027 shares in the last quarter. Sei Investments Co. raised its stake in CareTrust REIT by 14.6% in the third quarter. Sei Investments Co. now owns 14,689 shares of the real estate investment trust's stock valued at $261,000 after purchasing an additional 1,867 shares in the last quarter. LPL Financial LLC raised its stake in CareTrust REIT by 21.7% in the third quarter. LPL Financial LLC now owns 15,994 shares of the real estate investment trust's stock valued at $285,000 after purchasing an additional 2,854 shares in the last quarter. Federated Hermes Inc. lifted its position in CareTrust REIT by 45.7% during the third quarter. Federated Hermes Inc. now owns 44,252 shares of the real estate investment trust's stock worth $787,000 after purchasing an additional 13,874 shares during the period. Finally, Guggenheim Capital LLC grew its stake in CareTrust REIT by 22.5% during the third quarter. Guggenheim Capital LLC now owns 112,632 shares of the real estate investment trust's stock worth $2,004,000 after buying an additional 20,700 shares in the last quarter. Institutional investors and hedge funds own 87.55% of the company's stock.

About CareTrust REIT

CareTrust REIT, Inc is a self-administered, publicly-traded real estate investment trust engaged in the ownership, acquisition, development and leasing of skilled nursing, seniors housing and other healthcare-related properties. With a nationwide portfolio of long-term net-leased properties, and a growing portfolio of quality operators leasing them, CareTrust REIT is pursuing both external and organic growth opportunities across the United States.

Featured Article: Why is the ROA ratio important?

Get a free copy of the Zacks research report on CareTrust REIT (CTRE)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for CareTrust REIT (NASDAQ:CTRE)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to [email protected]

Featured Article: Technical Analysis of Stocks and What It Means



7 Low-Priced Dividend Stocks Under $10

The recent trading activity surrounding low-priced stocks like GameStop (NYSE:GME) is a reminder to investors of the high-risk nature involved with these stocks. Often when a stock trades for under $10 (also termed a penny stock), it is trading that low for a reason. The company may not be profitable, or in the case of GameStop, it finds itself with a business model that no longer fits with consumer trends.

But that’s not always the case. It is possible to find low-priced stocks, even penny stocks, that offer great value. This is particularly true if the stock offers investors a dividend. Dividend-earning stocks are a diversification source for a consumer’s portfolio, particularly if the dividend gets reinvested. It’s literally like paying yourself for owning the stock.

And the stocks in this presentation look ready also to deliver some additional stock price growth that can increase your total return.

View the "7 Low-Priced Dividend Stocks Under $10".


MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.